Wagner M. Zago
Chief Tech/Sci/R&D Officer chez PROTHENA CORPORATION PLC
Profil
Wagner M.
Zago is currently the Chief Scientific Officer at Prothena Corp.
Plc since 2017.
Prior to this, he worked as a Scientist at Elan Pharmaceuticals LLC from 2006 to 2012.
Dr. Zago completed his graduate and doctorate degrees at the University of Sao Paulo and his undergraduate degree at Universidade Federal De Sao Paulo.
Postes actifs de Wagner M. Zago
| Sociétés | Poste | Début |
|---|---|---|
| PROTHENA CORPORATION PLC | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Anciens postes connus de Wagner M. Zago
| Sociétés | Poste | Fin |
|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 02/01/2012 |
Formation de Wagner M. Zago
| University of Sao Paulo | Doctorate Degree |
| Universidade Federal De Sao Paulo | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
